Delivery Order SPE2DB20D2014-SPE2DB25FD01Y
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,420.47 to AmerisourceBergen Drug Corp for 90 tablets of Meloxicam 15 mg, with a completion date of February 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count), with a ceiling value of $1,838.08 and a firm fixed price structure. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance and serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Meloxicam 15 mg tablet units (100 count) valued at $1,149.80 on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Meloxicam is a nonsteroidal anti-inflammatory drug commonly used in military and...
- This federal contract award, identified as SPE2DX15D3005|SPE2DX25F3MQX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $17,697.34, is for the delivery of 4,566,307,554 units of Meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through November 4, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,222.56 firm fixed price delivery order is for the supply of 180 tablets of the medication Meloxicam 15 mg. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential...
- The Defense Logistics Agency Troop Support Medical awarded a $253,960 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 bottles of 15mg meloxicam tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order runs from June 29, 2023 through June 30, 2023 to supply the generic nonsteroidal anti-inflammatory drug to DLA Troop Support Medical in support of their mission to provision the United States military, veterans, and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,213.44 to AmerisourceBergen Drug Corp on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,578.09 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. The contract, issued on August 14, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $108,554.87 to AmerisourceBergen Drug Corp on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...